尿DKK3反映肾纤毛病严重程度并预测短期肾功能下降
研究在247名个体(含195名肾纤毛病患儿和52名健康对照)的357份点尿样本中检测尿DKK3/肌酐比值,发现各疾病组均显著高于健康对照(11 pg/mg,P < 0.001),且与CKD分期显著相关(P < 0.0001)。uDKK3 >4.700 pg/mg与更大的年eGFR下降独立相关(P = 0.0029),但无法区分不同纤毛病亚型(P = 0.2637)。
要点
- 肾纤毛病患儿uDKK3/肌酐比值显著高于健康对照。
- uDKK3水平与CKD分期显著相关,不受其他临床参数影响。
- uDKK3 >4.700 pg/mg提示年eGFR下降更快,独立于诊断和eGFR。
核心结论
- 在肾纤毛病中,uDKK3是评估疾病严重程度和估计短期肾功能下降的标志物。
研究设计与样本
- 研究纳入247名个体(195名肾纤毛病患儿及52名年龄匹配健康对照)的357份点尿样本,检测uDKK3浓度并与CKD分期及年eGFR下降相关分析。
主要发现
- 各疾病组uDKK3/肌酐比值中位数均显著高于健康对照(11 pg/mg,P < 0.001):NPH 1.219 pg/mg、HNF1B 731 pg/mg、BBS 541 pg/mg、ARPKD 437 pg/mg。
- 所有疾病组中uDKK3水平与CKD分期显著相关(P < 0.0001),无其他临床参数有相关影响。
- uDKK3 >4.700 pg/mg与显著更大的年eGFR下降相关,独立于诊断和eGFR(P = 0.0029)。
- 肾小球疾病uDKK3水平有低于肾纤毛病的趋势,但各纤毛病亚型间无鉴别差异(P = 0.2637)。
临床怎么用
- 可将uDKK3作为肾纤毛病患儿疾病严重程度和短期肾功能下降风险的评估指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Phenotypic heterogeneity and unpredictability of individual disease progression present enormous challenges in ultrarare renal ciliopathies. The tubular-derived glycoprotein, Dickkopf-related protein 3 (DKK3) is a promising biomarker for kidney fibrosis and prediction of kidney function decline. Here, we measured urinary DKK3 (uDKK3) levels in 195 pediatric patients with renal ciliopathy to assess its potential as a discriminative and prediction marker. METHODS: uDKK3 concentration was measured in 357 spot urine samples from 247 individuals, including 52 healthy age-matched controls. Disease entities comprised nephronophthisis (NPH) (n = 37), autosomal recessive polycystic kidney disease (ARPKD) (n = 61), Bardet Biedl syndrome (BBS) (n = 57), and hepatocyte nuclear factor 1 beta (HNF1B)-nephropathy (n = 40). The results were correlated with chronic kidney disease (CKD) stage and annual estimated glomerular filtration rate (eGFR) decline. RESULTS: Median uDKK3-to-creatinine ratios (uDKK3/crea) in all disease entities were significantly higher compared with healthy controls (11pg/mg uDKK3/crea, P < 0.001): NPH, 1.219 pg/mg; HNF1B, 731 pg/mg; BBS, 541 pg/mg; and ARPKD, 437 pg/mg. A significant correlation of CKD stage with uDKK3 levels was observed for all disease entities (P < 0.0001) with no other clinical parameter having a relevant impact. In our cohort, uDKK3 values >4.700 pg/mg were associated with a significantly greater annual eGFR loss independently of diagnosis and eGFR (P = 0.0029). Although we observed a trend toward lower uDKK3 levels in glomerulopathies compared to renal ciliopathies, there was no discriminative difference between individual ciliopathy entities (P = 0.2637). CONCLUSION: In renal ciliopathies, uDKK3 is a marker to assess disease severity and estimate short-term kidney function decline.
引用
- Dahmer-Heath M, Gerß J, Fliser D, et al. Urinary Dickkopf-3 Reflects Disease Severity and Predicts Short-Term Kidney Function Decline in Renal Ciliopathies. Kidney Int Rep. 2024. PMID: 39810774. doi:10.1016/j.ekir.2024.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。